These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 3236630)
1. [Pharmacotherapy of cardiogenic shock and acute circulatory insufficiency based on bedside hemodynamic monitoring]. Czarnecki W Kardiol Pol; 1988; 31(7):439-48. PubMed ID: 3236630 [No Abstract] [Full Text] [Related]
2. [Hemodynamic principles of the therapy of cardiogenic shock and acute circulatory failure]. Czarnecki W Kardiol Pol; 1988; 31(7):428-38. PubMed ID: 2467035 [No Abstract] [Full Text] [Related]
3. [Cardiac insufficiency and shock caused by acute myocardial infarction. Manipulation of hemodynamic parameters]. Campagna C; Franco L; Perniola V Minerva Anestesiol; 1983 Nov; 49(11):653-8. PubMed ID: 6669276 [No Abstract] [Full Text] [Related]
4. [Emergencies in dilated cardiomyopathy and myocarditis]. Paleev NP; Mravian SP; Gurevich MA; Odinokova VA Kardiologiia; 1992; 32(11-12):107-10. PubMed ID: 1297869 [No Abstract] [Full Text] [Related]
5. [Significance of hemodynamic monitoring in acute myocardial infarct]. De Marchi M; De Bernardi A; Sclavo MG; Bevilacqua R; Piccinino C; Minelli M; Bottone W; Angelino PF Minerva Cardioangiol; 1981 Apr; 29(4):115-22. PubMed ID: 7242942 [No Abstract] [Full Text] [Related]
6. Hemodynamic monitoring and vasodilator therapy in acute left ventricular failure. Preliminary report on a new vasodilator, tolmesoxide. Mullie A; Lust P; Nievel J; Penninckx J; Vanhove L; Van Hoonacker G; Vendevelde K; Fenwick J; Coghill J Acta Anaesthesiol Belg; 1980; 31 Suppl():147-54. PubMed ID: 7457056 [TBL] [Abstract][Full Text] [Related]
7. Use of hemodynamics to differentiate pathophysiologic causes of cardiogenic shock. Daily EK Crit Care Nurs Clin North Am; 1989 Sep; 1(3):589-602. PubMed ID: 2684244 [TBL] [Abstract][Full Text] [Related]
8. [Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction]. Ruksin VV Sov Med; 1985; (2):54-6. PubMed ID: 3992326 [No Abstract] [Full Text] [Related]
9. [Pharmacotherapy of severe heart failure with inodilators--new approaches]. Baumann G; Hader O Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110 [TBL] [Abstract][Full Text] [Related]
15. [High-dose nitroglycerin in cardiogenic shock]. Guglina ME Klin Med (Mosk); 1997; 75(6):27-30. PubMed ID: 9273395 [TBL] [Abstract][Full Text] [Related]
16. [Shock caused by myocardial infarction--various problems of etiopathogenesis and treatment]. Kuch J Kardiol Pol; 1985; 28(2):157-64. PubMed ID: 3900516 [No Abstract] [Full Text] [Related]
17. Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock. Simoons ML; Muskens G; Hugenholtz PG Herz; 1983 Feb; 8(1):34-40. PubMed ID: 6832691 [TBL] [Abstract][Full Text] [Related]
18. [Hemodynamic effect of dobutamine in cardiogenic shock]. Coma Canella I; López-Sendón J Rev Esp Cardiol; 1981; 34(6):483-9. PubMed ID: 7339730 [No Abstract] [Full Text] [Related]
19. Bedside hemodynamic monitoring in the cardiac care unit. Chatterjee K Cardiovasc Clin; 1985; 15(1):253-68. PubMed ID: 3842330 [TBL] [Abstract][Full Text] [Related]
20. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine. El Mokhtari NE; Arlt A; Meissner A; Lins M Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]